Amendment No. 3

Names of Reporting Persons

Stonehill Capital Management LLC

Check the Appropriate Box If a Member of a Group (See Instructions)

a. ☐ b. ☐

SEC Use Only

Citizenship or Place of Organization

Delaware, USA

SC 13G/A 1 d101954dsc13ga.htm AMENDMENT NO. 3 Amendment No. 3

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G/A

(Amendment No. 5)*

Under the Securities Exchange Act of 1934

Trinity Biotech plc

(Name of Issuer)

Class ‘A’ Ordinary Shares represented by American Depositary Shares

(Title of Class of Securities)

896438306**

(CUSIP Number)

December 31, 2020

(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☒ Rule 13d-1(c)

☐ Rule 13d-1(d)

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

**	This CUSIP number applies to the American Depositary Shares.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Page 2 of 15 Pages

(1)	Based on 20,901,703 American Depositary Shares outstanding as reported by the Issuer. Each American Depositary Share reported on this Schedule 13G represents four Class ‘A” Ordinary Shares.

Page 3 of 15 Pages

(1)	Based on 20,901,703 American Depositary Shares outstanding as reported by the Issuer. Each American Depositary Share reported on this Schedule 13G represents four Class ‘A” Ordinary Shares.

Page 4 of 15 Pages

(1)	Based on 20,901,703 American Depositary Shares outstanding as reported by the Issuer. Each American Depositary Share reported on this Schedule 13G represents four Class ‘A” Ordinary Shares.

Page 5 of 15 Pages

(1)	Based on 20,901,703 American Depositary Shares outstanding as reported by the Issuer. Each American Depositary Share reported on this Schedule 13G represents four Class ‘A” Ordinary Shares.

Page 6 of 15 Pages

(1)	Based on 20,901,703 American Depositary Shares outstanding as reported by the Issuer. Each American Depositary Share reported on this Schedule 13G represents four Class ‘A” Ordinary Shares.

Page 7 of 15 Pages

(1)	Based on 20,901,703 American Depositary Shares outstanding as reported by the Issuer. Each American Depositary Share reported on this Schedule 13G represents four Class ‘A” Ordinary Shares.

Page 8 of 15 Pages

(1)	Based on 20,901,703 American Depositary Shares outstanding as reported by the Issuer. Each American Depositary Share reported on this Schedule 13G represents four Class ‘A” Ordinary Shares.

Page 9 of 15 Pages

(1)	Based on 20,901,703 American Depositary Shares outstanding as reported by the Issuer. Each American Depositary Share reported on this Schedule 13G represents four Class ‘A” Ordinary Shares.

Page 10 of 15 Pages

(1)	Based on 20,901,703 American Depositary Shares outstanding as reported by the Issuer. Each American Depositary Share reported on this Schedule 13G represents four Class ‘A” Ordinary Shares.

Page 11 of 15 Pages

(1)	Based on 20,901,703 American Depositary Shares outstanding as reported by the Issuer. Each American Depositary Share reported on this Schedule 13G represents four Class ‘A” Ordinary Shares.

Page 12 of 15 Pages


ITEM 1(a).	NAME OF ISSUER:

	Trinity Biotech plc

ITEM 1(b).	ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES:

	IDA Business Park, Bray, Co. Wicklow, Ireland

ITEM 2(a).	NAME OF PERSON FILING:

This amended filing of Schedule 13G is being filed on behalf of the following persons (the “Reporting Persons”):

	(i)	Stonehill Capital Management LLC (“Management”)

	(ii)	Stonehill Institutional Partners, L.P. (“Fund”)

	(iii)	Stonehill Master Fund Ltd. (“Master”)

	(iv)	John Motulsky (“Motulsky”)

	(v)	Christopher Wilson (“Wilson”)

	(vi)	Jonathan Sacks (“Sacks”)

	(vii)	Peter Sisitsky (“Sisitsky”)

	(viii)	Michael Thoyer (“Thoyer”)

	(iv)	Michael Stern (“Stern”)

	(x)	Samir Arora (“Arora”)

ITEM 2(b).	ADDRESS OF PRINCIPAL BUSINESS OFFICE:

	c/o Stonehill Capital Management LLC 320 Park Ave. 26^th Floor New York, NY 10022


ITEM 2(c).	CITIZENSHIP:

	Management:	Delaware limited liability company
	Fund:	Delaware limited partnership
	Master:	Cayman Islands exempted company
	Motulsky:	US Citizen
	Wilson:	US Citizen
	Sacks:	US Citizen
	Sisitsky:	US Citizen
	Thoyer:	US Citizen
	Stern:	US Citizen
	Arora:	US Citizen

ITEM 2(d).	TITLE OF CLASS OF SECURITIES:

Class ‘A’ Ordinary Shares, par value US$0.0109 (held through American Depositary Shares (CUSIP 896438306), each representing four Class ‘A’ Ordinary Shares).

ITEM 2(e).	CUSIP NUMBER:

	896438306

ITEM 3.	IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B), OR 13D-2(B) OR (C) CHECK WHETHER THE PERSON FILING IS A:

	Not applicable.

Page 13 of 15 Pages


ITEM 4.		OWNERSHIP:

The information in items 1 and 5 through 11 on the cover pages (pp. 2 -11) on this Schedule 13G is hereby incorporated by reference. The amounts of securities reported as beneficially owned on this Schedule 13G are the number of American Depositary Shares that may be deemed to be beneficially owned by the Reporting Persons. Each American Depositary Share represents four of the Issuer’s Class ‘A’ Ordinary Shares.

ITEM 5.		OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:

If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities check the following. ☒

ITEM 6.		OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:

		Not applicable.

ITEM 7.		IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:

		Not applicable.

ITEM 8.		IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF A GROUP:

		Not applicable.

ITEM 9.		NOTICE OF DISSOLUTION OF GROUP:

		Not applicable.

ITEM 10.		CERTIFICATION

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Page 14 of 15 Pages

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


Dated:		February 12, 2021


STONEHILL CAPITAL MANAGEMENT LLC*

By:		/s/ Paul D. Malek
		Paul D. Malek
		An Authorized Signatory of a Member

STONEHILL INSTITUTIONAL PARTNERS, L.P. *

By:		/s/ Paul D. Malek
		Paul D. Malek
		An Authorized Signatory of Stonehill General Partner, LLC, its general partner

STONEHILL MASTER FUND LTD.*

By:		/s/ Paul D. Malek
		Paul D. Malek
		An Authorized Signatory of Stonehill General Partner, LLC, its investment adviser

JOHN MOTULSKY*

/s/ Paul D. Malek

Paul D. Malek

Attorney-in-Fact for John Motulsky

CHRISTOPHER WILSON*

/s/ Paul D. Malek

Paul D. Malek

Attorney-in-Fact for Christopher Wilson

JONATHAN SACKS*

/s/ Paul D. Malek

Paul D. Malek

Attorney-in-Fact for Jonathan Sacks

PETER SISITSKY*

/s/ Paul D. Malek

Paul D. Malek

Attorney-in-Fact for Peter Sisitsky

MICHAEL THOYER*

/s/ Paul D. Malek

Paul D. Malek

Attorney-in-Fact for Michael Thoyer

MICHAEL STERN*

/s/ Paul D. Malek

Paul D. Malek

Attorney-in-Fact for Michael Stern

SAMIR ARORA*

/s/ Paul D. Malek

Paul D. Malek

Attorney-in-Fact for Samir Arora

The Reporting Persons disclaim beneficial ownership in the shares reported herein except to the extent of their pecuniary interest therein, and this report shall not otherwise be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 13(d) or Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purposes.

Page 15 of 15 Pages

EXHIBIT 1

AGREEMENT OF JOINT FILING

Stonehill Capital Management LLC, Stonehill Institutional Partners, L.P., Stonehill Master Fund Ltd., John Motulsky, Christopher Wilson, Peter Sisitsky, Michael Thoyer, Jonathan Sacks, Michael Stern and Samir Arora hereby agree that the Statement on Schedule 13G to which this agreement is attached as an exhibit as well as all future amendments to such Statement, shall be filed jointly on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended.

Dated: February 12, 2021


STONEHILL CAPITAL MANAGEMENT LLC

By:		/s/ Paul D. Malek
		Paul D. Malek
		An Authorized Signatory of a Member

STONEHILL INSTITUTIONAL PARTNERS, L.P. *

By:		/s/ Paul D. Malek
		Paul D. Malek
		An Authorized Signatory of Stonehill General Partner, LLC, its general partner

STONEHILL MASTER FUND LTD.*

By:		/s/ Paul D. Malek
		Paul D. Malek
		An Authorized Signatory of Stonehill General Partner, LLC, its investment adviser

JOHN MOTULSKY

/s/ Paul D. Malek

Paul D. Malek

Attorney-in-Fact for John Motulsky

CHRISTOPHER WILSON

/s/ Paul D. Malek

Paul D. Malek

Attorney-in-Fact for Christopher Wilson

JONATHAN SACKS

/s/ Paul D. Malek

Paul D. Malek

Attorney-in-Fact for Jonathan Sacks

PETER SISITSKY

/s/ Paul D. Malek

Paul D. Malek

Attorney-in-Fact for Peter Sisitsky

MICHAEL THOYER

/s/ Paul D. Malek

Paul D. Malek

Attorney-in-Fact for Michael Thoyer

MICHAEL STERN

/s/ Paul D. Malek

Paul D. Malek

Attorney-in-Fact for Michael Stern

SAMIR ARORA

/s/ Paul D. Malek

Paul D. Malek

Attorney-in-Fact for Samir Arora

SEC Form SC 13G/A filed